Opus Genetics Inc
(IRD)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,791 | 17,888 | -16,053 | -11,522 | -6,595 |
| Depreciation Amortization | 1 | 4 | 3 | 2 | 1 |
| Accounts receivable | -1,536 | -1,298 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,152 | -515 | -125 | 302 | -5 |
| Other Working Capital | 1,313 | -5,555 | 72 | 558 | -105 |
| Other Operating Activity | 1,215 | 3,790 | 1,626 | 681 | 534 |
| Operating Cash Flow | $-3,646 | $14,314 | $-14,477 | $-9,979 | $-6,170 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 4,455 | 4,336 | 3,093 | 1,235 |
| Other Financing Activity | 0 | -669 | -538 | -623 | -353 |
| Financing Cash Flow | $N/A | $3,786 | $3,798 | $2,470 | $882 |
| Beginning Cash Position | 42,634 | 24,534 | 24,534 | 24,534 | 24,534 |
| End Cash Position | 38,988 | 42,634 | 13,855 | 17,025 | 19,246 |
| Net Cash Flow | $-3,646 | $18,100 | $-10,679 | $-7,509 | $-5,288 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,646 | 14,314 | -14,477 | -9,979 | -6,170 |
| Free Cash Flow | -3,646 | 14,314 | -14,477 | -9,979 | -6,170 |